NASDAQ
Instadose Pharma Corp. (INSD) has a eps (basic) of $-0.00 as of Tuesday, November 30, 2021. Basic EPS divides net income by the weighted average number of common shares outstanding, measuring profit allocated to each share.
No price data available for this timeframe.